financetom
Business
financetom
/
Business
/
US spot ether ETFs see net inflows of $106 million on first day
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US spot ether ETFs see net inflows of $106 million on first day
Jul 24, 2024 11:17 AM

(Reuters) - The nine exchange-traded funds (ETFs) tied to the spot price of ether, the world's second-largest cryptocurrency, scooped up net inflows of $106 million on Tuesday as they began trading on U.S. stock exchanges, according to data from CF Benchmarks and several trading firms.

The funds that pulled in most of those assets were sponsored by the same firms that emerged as the biggest winners following January's debut of spot bitcoin ETFs, CF Benchmarks, a digital asset index provider, noted.

BlackRock's ( BLK ) iShares Ethereum Trust ETF, led the pack with $266.5 million in inflows, closely followed by Bitwise Ethereum ETF ( ETHW ), which had inflows of $204 million. The Fidelity Ethereum Fund attracted $71 million in assets.

The Grayscale Ethereum Trust ( ETHE ), which converted into an ETF from a publicly traded trust on Tuesday, launched with more than $9 billion in assets and a fee well above the range of 0.20% to 0.25% of 2.5%. It saw outflows of $484 million, according to CF Benchmarks and traders. That figure is well above the first-day outflows from Grayscale's converted bitcoin ETF in January, which totaled only $95.1 million in spite of the larger size of that bitcoin ETF.

In a note published after the market's close Tuesday, crypto market-making firm Wintermute Trading noted that investors appear to be rotating out of the Grayscale ETF in favor of other, less costly offerings.

A newly launched lower-cost ETF, the Grayscale Ethereum Mini Trust ( ETH ), which levies a fee of only 0.15%, may have picked up some of those assets. It saw inflows of $15.1 million on Tuesday.

"The real money interest was strong enough to deem the launch a marginal success," noted Wintermute in its analysis of the initial trading volume of and flows into the new ETFs.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Safety Shot Appoints Markita Russell Finance Chief
Safety Shot Appoints Markita Russell Finance Chief
Aug 1, 2025
04:51 AM EDT, 08/01/2025 (MT Newswires) -- Safety Shot ( SHOT ) said late Thursday it has appointed Markita Russell as chief financial officer. Russell, previously its controller since August 2021, brings over 30 years of financial and accounting experience, the company said. ...
SAP to Acquire SmartRecruiters
SAP to Acquire SmartRecruiters
Aug 1, 2025
04:56 AM EDT, 08/01/2025 (MT Newswires) -- SAP (SAP) agreed to acquire SmartRecruiters, a talent acquisition software provider, to boost its all-in-one human capital management suite, the companies said Friday. The acquisition would streamline hiring, improve candidate experience and deliver AI-powered insights into recruitment by integrating SmartRecruiters' platform with SAP's existing HR tools. The financial terms of the deal, which...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
LENZ Therapeutics Says FDA Approved Eye Drop to Treat Loss of Near Vision
LENZ Therapeutics Says FDA Approved Eye Drop to Treat Loss of Near Vision
Aug 1, 2025
04:50 AM EDT, 08/01/2025 (MT Newswires) -- LENZ Therapeutics ( LENZ ) said late Thursday the US Food and Drug Administration has approved its eye drop, VIZZ 1.44%, to treat adults with presbyopia, the loss of near vision associated with aging. The company said the product will be commercially available by mid-Q4, with US samples expected as soon as October....
Copyright 2023-2026 - www.financetom.com All Rights Reserved